Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Protective effect of morin on cardiac mitochondrial function during isoproterenol-induced myocardial infarction in male Wistar rats
Because retatrutide has not yet received regulatory approval in the UK, there is currently no defined patient population for whom it is formally indicated
What the Research Shows Recent research on semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) has revealed concerning trends about body composition changes: A 2023 analysis of STEP trial data found that approximately 39% of weight lost on semaglutide was lean body mass 1 Research on tirzepatide showed similar patterns, with 30-40% of total weight loss coming from lean tissue 2 Comparative studies indicate GLP-1 users may lose more muscle than people losing weight through diet and exercise alone 3 For context: if you lose 50 pounds on a GLP-1 medication, 15-20 pounds might be muscle mass
Potential protective effect of selenium-enriched lactobacillus plantarum on cadmium-induced liver injury in mice
Phase 3 TRIUMPH trials are ongoing, with several readouts expected throughout 2026
US$ 20.81
US$ 22.59
US$ 26.35
US$ 22.31
US$ 24.70
